Objective: We investigated the effect of our quality control (QC) program on the management strategy, completeness of the surgery, and clinical outcomes in advanced ovarian cancer. Methods: A retrospective review of medical records from January 2005 to December 2019 identified 129 patients with advanced ovarian cancer. Cases were categorized into group 1 (2005–2013) and group 2 (2014–2019) before and after implementation of the QC program.Comparisons included clinicopathological variables, operative details, recurrence and survival outcomes. Results: In Group 2 (n=44), after QC program implementation, primary debulking surgery (PDS) decreased (87.1% vs. 63.6%) and interval debulking surgery (IDS) increased (12.9% vs.36.4%), indicating a shift in surgical strategy. Optimal resection rates improved significantly for PDS in group 2 (50.0% to 75.0%, p=0.007) and remained high for IDS in both groups (81.8% vs. 81.3%, p>0.999). Post-QC, advanced debulking procedures and co-operation with other departments increased in the IDS (p<0.05). Intra/post-operative complication rates were statistically comparable (p>0.05), whereas postoperative hospital stay was significantly shorter in group 2 (17 days vs. 22 days, p=0.001). Median recurrence-free survival increased after QC, although not statistically significant (19.18 months vs. 25.38 months, p=0.855). Conclusion With QC program, treatment strategies and clinical outcomes were significantly improved in advanced ovarian cancer. Systematic QC monitoring program should be considered as routine surveillance for better surgical outcomes.

Objectives: This study investigated the awareness and acceptance of digital therapeutics (DTx) among psychiatrists in South Korea, providing empirical insights to support future clinical implementation and dissemination. Methods: An online survey targeting 50 psychiatrists was conducted from October 2024 to February 2025. Descriptive statistics were performed on completed responses (n=36), focusing on DTx-related awareness and acceptance. Results: Most participants were aware of DTx, but few had experience prescribing it. They had positive expectations of increased treatment options and efficacy, with most information obtained through exhibitions and conferences. The key factors influencing the intention to use included reimbursement availability and the feasibility of integration with the electronic medical records. Many were motivated by interest in novel treatments and were willing to use DTx if peer adoption increased. The primary concern was uncertainty around reimbursement, and DTx was generally preferred as an adjunctive treatment. The appropriate cost for six sessions was considered to be 150000 KRW (approximately 110 USD) or less. The participants emphasized evidence-based effectiveness, convenience, and efficiency when promoting patient engagement. The need for incorporating DTx education into psychiatric residency training was also recognized. Conclusion This study is the first of its kind in South Korea to explore psychiatrists’ perspectives on DTx, offering foundational insights to help develop policy and education strategies for clinical and institutional implementation.